
Mitigate 200mg Tablet SR
Marketer
Staunch Health Care Pvt Ltd
Salt Composition
Aceclofenac (200mg)
Overview Mitigate 200mg Tablet SR
ReliefTab 200mg Extended-Release tablets offer pain relief and reduce inflammation. Indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, ReliefTab should be administered precisely as directed by your physician. To minimize stomach discomfort, take with food or milk. Consistent, timely intake maximizes therapeutic benefit. Continue treatment as prescribed until your doctor advises otherwise. Common side effects may include nausea, vomiting, indigestion, and stomach pain. Dizziness, drowsiness, or blurred vision are also possible. Prolonged use may necessitate regular monitoring of kidney and liver function, along with blood tests. Serious complications, including stomach ulcers and kidney issues, are potential risks associated with extended therapy. ReliefTab 200mg Extended-Release is contraindicated during pregnancy and breastfeeding.
Uses of Mitigate 200mg Tablet SR
Analgesia
Major Benefits of Mitigate 200mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 200mg Mitigate SR tablet should be administered with a meal.
Common Side effects of Mitigate 200mg Tablet SR:
- Vomiting
- Stomach pain/epigastric pain
- Nausea
- Indigestion
- Diarrhea
- Heartburn
- Loss of appetite
How to use Mitigate 200mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mitigate 200mg Extended-Release tablets should be administered with a meal.
How Mitigate 200mg Tablet SR works:
Mitigate 200mg Extended-Release tablets are a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation by inhibiting the production of specific inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Mitigate 200mg sustained-release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Mitigate 200mg Sustained-Release tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Mitigate 200mg sustained-release tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a 200mg Mitigate SR tablet may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Exercise caution when prescribing Mitigate 200mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Mitigate 200mg SR tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Mitigate 200mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Mitigate 200mg SR tablets are contraindicated in patients with severe hepatic dysfunction. Close monitoring of liver function is recommended during treatment.
What if you forget to take Mitigate 200mg Tablet SR :
Should you forget a dose of Mitigate 200mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mitigate 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Dichlorobenzene derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Action Category | Non-selective COX-1 and COX-2 inhibitors (acetic acid derivatives) |
